Skip to main content

and
  1. Article

    Open Access

    Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

    Lauren K. Shea, Kazuhito Honjo, David T. Redden, Edlue Tabengwa in Blood Cancer Journal (2019)

  2. No Access

    Article

    Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

    Exome analysis of chemical-carcinogen-induced mouse tumours provides evidence for T-cell-mediated immunoselection as a mechanism of immunoediting.

    Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt, Charles G. Rickert in Nature (2012)